JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
VGP NV
XBRU:VGP
|
BE |
|
eFFECTOR Therapeutics Inc
F:LWK1
|
US |
|
Guoguang Electric Co Ltd Chengdu
SSE:688776
|
CN |
|
A
|
AB&Company Co Ltd
TSE:9251
|
JP |
|
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
MY |
|
Daibiru Corp
TSE:8806
|
JP |
|
A
|
Ashok Alco-Chem Ltd
BSE:524594
|
IN |
|
Natural Resource Partners LP
NYSE:NRP
|
US |
|
M
|
M3-Brigade Acquisition V Corp
NASDAQ:MBAV
|
US |
Cash Flow Statement
Cash Flow Statement
JSP Industrial Pharmacy (Thailand) PCL
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
39
|
32
|
32
|
30
|
11
|
(13)
|
(24)
|
(17)
|
(4)
|
(5)
|
35
|
28
|
23
|
49
|
46
|
(33)
|
(25)
|
(12)
|
(32)
|
45
|
|
| Depreciation & Amortization |
27
|
22
|
22
|
22
|
22
|
23
|
24
|
26
|
30
|
34
|
41
|
47
|
52
|
56
|
59
|
62
|
65
|
67
|
69
|
70
|
|
| Other Non-Cash Items |
34
|
29
|
23
|
20
|
17
|
10
|
6
|
10
|
9
|
8
|
(29)
|
(24)
|
(24)
|
(13)
|
35
|
134
|
142
|
146
|
145
|
57
|
|
| Cash Taxes Paid |
7
|
10
|
13
|
9
|
9
|
6
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
14
|
10
|
10
|
10
|
10
|
9
|
8
|
7
|
7
|
8
|
12
|
13
|
16
|
17
|
16
|
17
|
17
|
16
|
15
|
14
|
|
| Change in Working Capital |
(40)
|
(22)
|
1
|
(20)
|
(52)
|
(39)
|
(22)
|
(24)
|
21
|
3
|
(16)
|
(11)
|
(2)
|
(14)
|
(22)
|
(31)
|
(49)
|
(74)
|
(80)
|
(41)
|
|
| Cash from Operating Activities |
61
N/A
|
62
+1%
|
78
+27%
|
52
-34%
|
(2)
N/A
|
(20)
-1 107%
|
(16)
+16%
|
(5)
+69%
|
56
N/A
|
40
-29%
|
30
-25%
|
40
+35%
|
49
+22%
|
79
+59%
|
118
+51%
|
132
+12%
|
133
+1%
|
128
-4%
|
101
-20%
|
131
+29%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(12)
|
(12)
|
(20)
|
(37)
|
(70)
|
(130)
|
(232)
|
(290)
|
(339)
|
(362)
|
(217)
|
(174)
|
(103)
|
(27)
|
(80)
|
(57)
|
(47)
|
(45)
|
(29)
|
(280)
|
|
| Other Items |
6
|
1
|
6
|
(21)
|
(183)
|
(343)
|
(318)
|
(179)
|
4
|
214
|
78
|
(29)
|
(49)
|
(101)
|
6
|
0
|
0
|
1
|
1
|
2
|
|
| Cash from Investing Activities |
(6)
N/A
|
(11)
-82%
|
(14)
-32%
|
(58)
-311%
|
(254)
-336%
|
(473)
-86%
|
(549)
-16%
|
(469)
+15%
|
(335)
+29%
|
(147)
+56%
|
(139)
+6%
|
(202)
-46%
|
(153)
+25%
|
(127)
+17%
|
(74)
+42%
|
(57)
+23%
|
(46)
+19%
|
(44)
+5%
|
(28)
+37%
|
(277)
-903%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
760
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
49
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(40)
|
(25)
|
(20)
|
(92)
|
(107)
|
(97)
|
(125)
|
(41)
|
(1)
|
(10)
|
54
|
58
|
45
|
45
|
(1)
|
(35)
|
(53)
|
(47)
|
(50)
|
179
|
|
| Cash Paid for Dividends |
0
|
(18)
|
(28)
|
(28)
|
0
|
(24)
|
(6)
|
(6)
|
0
|
0
|
(11)
|
(0)
|
0
|
0
|
(4)
|
(15)
|
(15)
|
(15)
|
(25)
|
(25)
|
|
| Other |
(14)
|
(10)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
41
|
41
|
37
|
(24)
|
(26)
|
(28)
|
(27)
|
(17)
|
(17)
|
(17)
|
10
|
11
|
|
| Cash from Financing Activities |
(54)
N/A
|
(54)
+1%
|
(58)
-8%
|
630
N/A
|
615
-2%
|
629
+2%
|
621
-1%
|
(54)
N/A
|
35
N/A
|
30
-13%
|
81
+167%
|
83
+2%
|
18
-78%
|
17
-8%
|
(32)
N/A
|
(67)
-107%
|
(85)
-27%
|
(79)
+7%
|
(65)
+18%
|
165
N/A
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
(3)
N/A
|
6
N/A
|
623
+11 072%
|
360
-42%
|
137
-62%
|
55
-60%
|
(528)
N/A
|
(245)
+54%
|
(77)
+68%
|
(29)
+63%
|
(80)
-178%
|
(85)
-7%
|
(32)
+62%
|
12
N/A
|
9
-27%
|
2
-77%
|
5
+141%
|
9
+88%
|
19
+106%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
48
N/A
|
50
+3%
|
58
+16%
|
15
-75%
|
(72)
N/A
|
(149)
-107%
|
(248)
-66%
|
(296)
-19%
|
(284)
+4%
|
(322)
-13%
|
(187)
+42%
|
(133)
+29%
|
(54)
+59%
|
52
N/A
|
38
-26%
|
75
+95%
|
86
+15%
|
83
-4%
|
73
-12%
|
(149)
N/A
|
|